Please ensure Javascript is enabled for purposes of website accessibility

Zeltiq Aesthetics Earnings: Keeping Up Appearances

By Rick Munarriz – Aug 8, 2016 at 7:35PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company behind the CoolScuplting fat cell freezing platform delivers another quarter of growth. It's revising its revenue guidance higher, again.

Image source: Zeltiq Aesthetics.  

Zeltiq Aesthetics (ZLTQ) has carved out a cozy living by making people feel better about the way they look on the outside, making Zeltiq's insides look pretty good in the process. Shares of Zeltiq Aesthetics moved higher in after-hours trading on Monday following its latest financial results. 

The company behind the CoolSculpting machines that use intense cold to freeze away fat cells continues to post healthy growth spurts. Revenue hit a record $89.5 million during Zeltiq's second quarter, 39% ahead of the prior year's showing. Putting the power of Zeltiq's healthy compounded growth in perspective, Zeltiq's top-line growth during the second quarter has risen by 90% in two years and 240% in three years.

Zeltiq's year-over-year growth during the first three months of the year had slowed to 25% -- its worst showing in nearly three years, according to S&P Global Market Intelligence data. Now it has bounced back with its second strongest percentage growth over the past five quarters.

System revenue clocked in at $39.5 million, 23% ahead of its showing a year earlier. It shipped 364 systems during the quarter, pushing its installed base up to 5,254 systems. Zeltiq has also been successful in moving add-on applicators that either speed up the procedure process or help the CoolSculpting machine tackle new treatment areas. 

The real growth at Zeltiq these days is coming from consumable revenue, essentially the money it generates for every treatment cycle. Consumable revenue soared 54% for the quarter. CoolSculpting machines completed 370,122 revenue cycles during the period, up 47% since the prior year.  

Zeltiq did post a small deficit for the period, a rare sight, as it had registered a loss only during the seasonally sleepy first quarter in each of the past three years. However, with gross margin on one hand that took a step back, given the product-mix shift to new add-on applicators, and a dramatic spike in sales and marketing costs on the other hand as the company put some muscle behind a national consumer-direct campaign, the red ink isn't a surprise. It's near-term pain for the sake of long-term gain.

CoolSculpting keeps heating up

CoolSculpting is finally starting to become a household brand. Zeltiq experienced 4 million visits to its informational website through the first half of this year, and its research shows that there are 30 million people potentially interested in its non-invasive procedures.

As CoolSculpting's applications grow -- it was originally cleared for love handles, but it's now tackling flanks, thighs, stomachs, and even double chins -- consumer acceptance should also continue to widen. 

Once again we see Zeltiq boosting its top-line guidance. It's now targeting $340 million to $350 million in revenue this year, up from its earlier outlook of $320 million to $325 million. This is something that's been routinely happening since 2013. The news isn't as comforting as we work our way down the income statement. It now sees a leaner gross-profit margin and a small loss for the year. 

Investors are still being rewarded with a 4% pop in after-hours trading on Zeltiq stock. They're valuing Zeltiq's ability to expand its CoolSculpting system installations over near-term profitability, and for now that's what the market finds aesthetically pleasing.

Rick Munarriz owns shares of Zeltiq Aesthetics. The Motley Fool recommends Zeltiq Aesthetics. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

ZELTIQ Aesthetics, Inc. Stock Quote
ZELTIQ Aesthetics, Inc.

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/07/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.